Researchers pool experience to examine discoid lupus diagnosis, outcomes in children

July 8, 2019
Significant differences in perceived risk factors for systemic disease along with other substantial differences exist in screening and treating…

In the Journals

Glucocorticoid discontinuation plan recommended for juvenile-onset dermatomyositis

June 24, 2019
A group of international researchers writing in Pediatric Rheumatology have proposed a plan for tapering and discontinuing glucocorticoids in…

In the Journals

No conclusive evidence found on optimum antibiotic treatment for cellulitis

June 21, 2019
Researchers were unable to identify the most effective antibiotic treatment for cellulitis, as no one antibiotic was superior over another based on…

In the Journals

Hidradenitis suppurativa increases risk for alopecia

June 18, 2019
In a study investigating the relationship between hidradenitis suppurativa and alopecia areata in a U.S. sample, those with hidradenitis suppurativa…

In the Journals

Cyclosporine, methotrexate pose less risk for serious infections in atopic dermatitis

June 5, 2019
In adults with atopic dermatitis, treatment with cyclosporine or methotrexate appears to have a lower rate of serious infections than mycophenolate…

In the Journals

Researchers propose pathogenesis of acute inflammatory edema

June 5, 2019
In a paper recently published in Journal of the American Academy of Dermatology, researchers proposed there is a three-part pathogenesis of acute…

In the Journals

Alterations in pathway activation found in hidradenitis suppurativa

May 6, 2019
Biological pathways are disrupted among patients with hidradenitis suppurativa, which suggests that inflammatory pathways, pathways of leucocyte…

Meeting News

Dermatology pearls for the rheumatologist: cutaneous lupus, dermatomyositis

May 6, 2019
DESTIN, Fla. — In a session here at Congress of Clinical Rheumatology, Joseph F. Merola, MD, MMSc, of Harvard Medical School and Brigham and…

FDA News

FDA approves Skyrizi for moderate to severe plaque psoriasis

April 25, 2019
AbbVie announced that the FDA has approved Skyrizi, an interleukin-23 inhibitor for treating moderate to severe plaque psoriasis in adults who are…

In the Journals

Calcinosis linked to greater disease severity, duration in juvenile dermatomyositis

January 17, 2019
Among patients with juvenile dermatomyositis, calcinosis was associated with longer active disease duration, disease severity and clinical features…

FDA News

FDA awards $18 million to fund trials of medical products for rare diseases

September 29, 2018
The FDA awarded more than $18 million in grants over the next 4 years to fund clinical trials of medical products intended to treat patients with…

FDA News

FDA approves Rituxan for pemphigus vulgaris

June 8, 2018
The FDA has approved rituximab for the treatment of adult patients with moderate-to-severe pemphigus vulgaris, a rare autoimmune blistering disease…

Meeting News

IAS 2018: Advances, collaboration in immune-mediated inflammatory diseases

April 26, 2018
BOSTON — Rheumatologists, gastroenterologists, dermatologists, immunologists and other health care providers who care for patients with…

FDA News

FDA declines proposed Rituxan, Herceptin biosimilars from Celltrion

April 6, 2018
The FDA has rejected approval of Celltrion’s biologics license applications for Truxima, a proposed rituximab biosimilar, and Herzuma, a…

In the Journals

Stem cell transplant improves overall, event-free survival in scleroderma

January 3, 2018
Myeloablative autologous stem cell transplantation improved long-term clinical outcomes, including overall survival and event-free survival, among…

In the Journals

Pneumocystis prophylaxis may be unnecessary in autoimmune blistering diseases

September 11, 2017
One patient in a large cohort of individuals with autoimmune blistering diseases developed pneumocystis pneumonia, suggesting that routine…

In the Journals

Enanthemas commonly observed in non-classic pityriasis rosea

August 15, 2017
Enanthemas were commonly reported among patients with non-classic forms of pityriasis rosea, including persistent and pediatric forms of the disease…

In the Journals

Two histopathologic patterns found in cutaneous lupus of the scalp

August 14, 2017
Histopathologic assessment of hair follicles in patients with chronic cutaneous lupus erythematosus of the scalp revealed two distinct patterns…

Phase 3 trial of Actemra for systemic sclerosis completes enrollment

August 11, 2017
This week, Genentech announced its phase 3 trial of Actemra for patients with systemic sclerosis has completed enrollment. The study will compare the…

Top five dermatology stories in July include psoriasis studies, FDA approval

July 31, 2017
Study results reporting that nail findings distinguished patients with psoriatic arthritis from those with psoriasis without arthritis was among the…

Healio Jobs